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Abstract: 
Objectives The aim of this study was to develop mucoadhesive oral strips 
using hot-melt extrusion as a continuous manufacturing process.    
Methods Powder blends of ketoconazole, a water insoluble drug; either 
hydroxypropyl methylcellulose (HPMC) or soluplus (SOL), sorbitol (SRB) 
and magnesium aluminometasilicate (MAS) were extruded to manufacture 
thin strips with 0.5 mm thickness. The presence of the inorganic 
metasilicate facilitated smooth processing of the extruded strips as it 
worked as an absorbent directly impacting on the extensive mixing of the 
drug/excipients inside the extruder barrel.  
Key findings The use of MAS also favoured the rapid hydration, swelling 
and eventual disintegration of the strips. Differential scanning calorimetry 
(DSC) and transmission X-ray diffraction (TXRD) analysis revealed the 
existence of the amorphous drug within the extruded strips. Scanning 
electron microscopy (SEM) and energy dispersive X-Ray (EDS) undertaken 
on the formulations showed a homogeneous drug distribution within the 
extruded strips.  
Conclusion The strips produced via continuous HME processing showed 
significantly faster release of KTZ compared to the bulk drug substance.  
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ABSTRACT 
 
Objectives The aim of this study was to develop mucoadhesive oral strips using hot-
melt extrusion as a continuous manufacturing process.   
Methods Powder blends of ketoconazole, a water insoluble drug; either 
hydroxypropyl methylcellulose (HPMC) or soluplus (SOL), sorbitol (SRB) and 
magnesium aluminometasilicate (MAS) were extruded to manufacture thin strips with 
0.5 mm thickness. The presence of the inorganic metasilicate facilitated smooth 
processing of the extruded strips as it worked as an absorbent directly impacting on 
the extensive mixing of the drug/excipients inside the extruder barrel.  
Key findings The use of MAS also favoured the rapid hydration, swelling and 
eventual disintegration of the strips. Differential scanning calorimetry (DSC) and 
transmission X-ray diffraction (TXRD) analysis revealed the existence of the 
amorphous drug within the extruded strips. Scanning electron microscopy (SEM) and 
energy dispersive X-Ray (EDS) undertaken on the formulations showed a 
homogeneous drug distribution within the extruded strips.  
Conclusion The strips produced via continuous HME processing showed 
significantly faster release of KTZ compared to the bulk drug substance. 
Keywords: Continuous manufacturing, ketoconazole, oral strips, energy dispersive 
X-Ray, surface analysis, amorphous. 
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Introduction 
‘Strips’ (commonly referred to as films) can be defined as thin sheets containing one 
or more polymers with or without a plasticizer and can effectively be used as a drug 
delivery system. Whilst, the solvent – casting approach – currently a pharmaceutically 
adopted process, allows better uniformity, flexibility and adjustable thickness, this 
approach is limited by low drug loading, high costs and time consumption for 
development. 
[1-3]
 Furthermore, the excessive use of various solvents to dissolve 
insoluble polymer or drug makes the solvent casting method questionable from the 
regulatory viewpoint. Moreover, the hazardous nature of most organic solvents and 
the residual solvents 
[4-7]
 left in the films may create significant environmental and 
health concerns. Therefore, there is increasing current interest in alternative 
technologies in the pharmaceutical industry to overcome some or all of the challenges 
currently associated with solvent film casting.  
Hot melt extrusion (HME) has been successfully exploited for the 
manufacturing of oral thin films or strips due to its unique advantages. 
[8]
 HME is a 
solvent free green technology, easy to scale up and operates in a continuous mode. 
[9-
11] 
Another key advantage of HME is that robust extruded films/strips can be obtained 
in a single processing step making the process economically viable. In a HME 
process, melt extruded strips are produced via feeding the blends of appropriate 
amounts of the relevant polymer(s), drug, plasticiser and other excipients into the 
preheated extruder barrel and conveying them with rotating screws into homogenous 
sheets. Other excipients can be added to enhance functionally important properties of 
the strips such as bioadhesive agents to ensure that the film adheres to the oral 
mucosal surface for the appropriate time periods in order to allow drug absorption. 
[8]
  
Various studies have been reported on the manufacture of oral strips using 
HME. Tumuluri et al., and Prodduturi et al., conducted extensive research on the use 
of HME for the manufacture of mucoadhesive buccal films with different matrix 
formers and additives. 
[12, 13]
 In an early investigation, the group found that the 
addition of plasticizers, such as triethyl citrate, PEG 2000/8000, or acetyltributyl 
citrate, allowed the manufacture of thin, flexible, and stable films when 
hydroxypropyl cellulose (HPC) was used as film forming polymer. 
[13]
 It was shown 
that the increase in the molecular weight of HPC decreased the release of drugs from 
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extruded films, which resulted in dissolution profiles exhibiting zero-order drug 
release. 
[14, 15]
 
Ketoconazole (KTZ) is an antifungal agent mainly used for the treatment of 
local and systemic fungal infections in various forms (e.g. oral tablets, topical creams, 
gels, aerosols, suspensions and shampoos). Due to its very poor water solubility (17 
µg/ml) and high permeability, KTZ is classified as Biopharmaceutics Classification 
System (BCS) class II drug. Increasing the solubility of KTZ is a challenging task as 
it significantly reduces the oral bioavailability of the drug and thus the therapeutic 
effectiveness. 
[15]
 We report to the best of our knowledge, a new case to manufacture 
KTZ based oral strips using inorganic excipients via a continuous HME processing 
and the physicochemical characterisation of the developed strips where the novelty of 
this paper lies. The distribution of the drug particles on the surface of the 
manufactured oral strips is also investigated as well as the strips’ hydration/swelling, 
mucoadhesion and mechanical properties. 
  
Materials and methods 
Materials 
Ketoconazole (KTZ) was purchased from Sigma Aldrich (Gillingham, UK). 
Hydroxypropyl methylcellulose K4 (HPMC) and magnesium aluminometasilicate 
(Neusilin, MAS) were kindly donated by Colorcon (Dartford, UK) and Fuji Chemical 
Industry Co., Ltd. (Japan), respectively. Soluplus (SOL) was kindly donated by 
BASF, Germany. Sorbitol (SRB) and polyethylene glycol 2000 (PEG) were provided 
by Roquette (Lestrem, France) and Fluka (Gillingham, UK). Sodium CMC was 
purchased from Sigma Aldrich (Gillingham, UK). The HPLC solvents were of 
analytical grade and purchased from Fisher Chemicals (Loughborough, UK). All 
materials were used as received.  
 
Drug/polymer miscibility determination 
The drug/polymer miscibility was determined by calculating Hansen
 
solubility 
parameters (δ) of both the drug and polymers. By considering the chemical structure 
and the orientations of all drug/polymers, the solubility parameters were calculated by 
using the following equation, which is known as Hoftyzer and Van Krevelen method: 
[16, 17]
 
Page 5 of 25 Journal of Pharmacy and Pharmacology
For Review Only
  
 
 
Here, 
 ,    ,  
Where δ is total solubility parameter calculated, Fdi is the constant (molar attraction) 
due to molar dispersion forces, F
2
pi is the constant (molar attraction) due to molar 
polarization forces, Ehi is the hydrogen bonding energy, and Vi  the group contribution 
to molar volume. 
 
Preparation of formulation blends and continuous HME processing 
KTZ formulations with HPMC and SOL as polymeric matrices and a drug loading 
ranging from 5-20% (w/w) (Table 1) were thoroughly mixed in a Turbula TF2 mixer 
(Basel, Switzerland) mixer in 100 g batches for 10 min each, prior to the extrusion 
process. About 1 g of powdered samples from each batch (physical mixture) was 
preserved in an air tight glass vial for further analyses. Appropriately weighted MAS, 
SRB and PEG were added to the Turbula mixtures prior to the extrusion process. 
Extrusion of all formulations were performed using a EuroLab 16 twin-screw extruder 
(Thermo Fisher, Germany) equipped with a specially designed die to produce strips of 
0.5 mm thickness and temperature profile at 
50
°
C/130
°
C/140
°
C/140
°
C/140
°
C/140
°
C/140
°
C/140
°
C/140
°
C/140
°
C (from feeding zone 
→ Die) temperature profiles. The screw speed maintained for all extrusions was 100 
rpm. The extrudates were fed continuously to a PFL-590 cutting machine (Kunshan 
Pingfenglong Trade Co., Ltd, China) and cut into strips of 1 cm x 5 cm (100 mg of 
KTZ in each strips).  
 
Hydration and swelling studies 
The hydration (swelling) profiles of the strips were determined using a modified 
method from that previously described. 
[18]
 Briefly, the strips were initially weighed 
δ = δd
2 +δp
2 +δh
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and the weight recorded as Wi and then placed in a Petri dish containing 10 mL of 0.1 
M PBS, pH 6.8 ± 0.1, at 37
°
C. At pre-determined time intervals (20 minutes), the 
liquid medium was removed, the strips blotted carefully with tissue paper to remove 
the surface-adhered liquid droplets and reweighed on an electronic balance and 
recorded as Wt. Fresh medium (10 ml) was then added to the already swollen strip 
and the process continued till maximum swelling was obtained (up to 80 minutes). 
The percentage of water uptake was calculated as follows: 
		

	% = 100	
 −

																2 
Where, Wt is the weight of the hydrated wafer at time t, and Wi is the initial weight of 
wafer. 
 
In vitro mucoadhesion studies 
Mucoadhesive measurements were performed on the strips using a previously 
reported method. 
[19]
 The strips (1 cm x 2 cm dimensions) were attached to a 75 mm 
diameter adhesive rig probe with a double sided adhesive tape on a TA.HD.plus 
Texture Analyser (Stable Micro Systems, Surrey, UK) fitted with a 5 kg load cell in 
tension mode. The model mucosal surface was gelatin gel which was allowed to set in 
a Petri-dish (diameter 88 mm). The set gelatin gel was equilibrated with 2% mucin 
solution (adjusted to pH of 6.8 ± 0.1) for 1 min and placed on the instrument platform. 
The probe, lined with the strip was lowered towards the gelatin surface at pre-test 
speed of 0.5 mm/s, test speed of 0.5 mm/s and post speed of 1.00 mm/s. The 
maximum force required to detach the strip on the upper probe from the mucosal 
surface, known as the peak adhesion force (PAF) was determined. The area under the 
curve (AUC) representing total work of adhesion (TWA) of the wafers was estimated 
from the force-distance plot whiles the cohesiveness of the samples was determined 
by the distance of travel.  
 
Scanning electron microscopy (SEM)/ energy dispersive X-Ray (EDS) analysis 
The spatial distribution of discreet chemical phases was evaluated using a cold-
cathode field-emission gun scanning electron microscope (Hitachi SU8030 FEG-
SEM, Japan) and Thermo-Noran (USA) EDS system with 30 mm
2
 window Ultra-Dry 
detector and Noran 7 software. The samples were secured to aluminium stubs with 
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Leit-C carbon cement and coated with carbon (Edwards 306 high vacuum carbon 
evaporation) before SEM/EDS analysis. The elemental distribution on the surface of 
the strips was investigated using EDS while surface analysis to characterize the 
morphology of strips was evaluated using SEM at nominal magnifications of x500 
and x1000. The accelerating voltage of the incident electron beam was set at 10 kV in 
order to minimize beam damage to the sample while maintaining adequate excitation. 
The raw X-ray maps were processed for background removal to give net-counts for 
each of the analytical X-ray lines. Chlorine (Cl) atoms were taken as a marker atom 
since it was only present in the structure of the drug. 
 
Thermal analysis 
The physical form of the pure drug, physical mixtures and extruded strips were 
examined by using a Mettler-Toledo 823e (Greifensee, Switzerland) differential 
scanning calorimeter. Samples were prepared in sealed aluminium pans (2-5 mg) with 
a pierced lid. The samples wer  heated at 10
°
C/min under nitrogen atmosphere in a 
temperature range between 0
°
C and 250
°
C.  
 
Transmission X-ray diffraction analysis 
A D8 Advantage X-ray diffractometer (Bruker AXS GmbH, Karlsure, Germany) was 
employed to study the crystallinity of KTZ on the extruded strips. The transmission 
diffractograms were acquired with Diffrac plus XRD Commander over a start to end 
diffraction 2θ angle of 2–40°, scan speed of 0.2 s and step size of 0.02 and a counting 
time of 0.4 s per step; 176 channels active on the PSD making a total counting time of 
70.4 s per step. The operating conditions were 40 kV and 40 mA with Cu Kα 
radiation. All acquired data were processed with EVA software for bulk substances 
and the extruded strips.  
 
In vitro drug release studies 
In vitro dissolution study of pure drug and extrudates was carried out by using a 
Varian 705 DS dissolution paddle apparatus (Varian Inc. North Carolina, US) at 100 
rpm and 37 ± 0.5
°
C. The dissolution medium pH was maintained at 6.8 by using 900 
ml of 0.2 M potassium dihydrogen phosphate buffer (adjusted with 2.0 M NaOH 
solution) for 2 h. The temperature was equilibrated to 37 ± 0.5
°
C. At predetermined 
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time intervals, samples were withdrawn for HPLC assay and replaced with fresh 
dissolution medium. All dissolution studies were performed in triplicate.  
 
HPLC analysis 
The release of KTZ from the prepared extrudates (strips) was determined by HPLC. 
An Agilent Technologies system equipped with a Sperisorb S50DS1 (150 mm x 4.6 
mm x 5 µm) column at 230 nm was used for the KTZ HPLC assay. The mobile phase 
consisted of methanol/water/triethyl amine (80: 20: 0.2, v/v/v). The flow rate was 1.5 
ml/min and the retention time of KTZ was about 2 min. The KTZ calibration curve 
(R
2 
= 0.999), at concentrations varying from 5 µg/ml to 100 µg/ml, were used to 
evaluate all the samples with 20 µl injection volume.  
 
Statistical analysis 
All statistical analysis of the data for swelling studies were conducted using Microsoft 
Excel 2013 (USA). Dissolution profiles were investigated for the significance of 
difference among the distribution of the independent variables using a non-parametric 
statistical test of significance - Kruskal–Wallis (Vassarstats, Poughkeepsie, 
NY  USA). 
 
Results and discussion 
Drug/polymer miscibility  
The prediction of drug/polymers miscibility prior to the selection of appropriate 
hydrophilic strips forming polymer in all extruded formulations was successfully 
determined by the solubility parameters (δ) using the Van Krevelen/ Hoftyzer 
equation 1. 
[17, 20]
 Generally, the drug/polymers miscibility is achieved via the 
optimised stability between the energy released by inter molecular interactions and 
intra molecular interactions within the components. 
[21]
 The theoretical approach 
derived from the solubility parameter suggests that compounds with similar δ values 
are likely to be miscible. The reason is that the energy of mixing from intramolecular 
interactions with particular components is then balanced with the energy of mixing 
from intermolecular interactions between the components (drug/polymer). Therefore, 
it has been demonstrated that compounds with ∆δ < 7 MPa
1/2
 are likely to be miscible 
and compounds with ∆δ > 10 MPa
1/2 
are likely to be immiscible.
 [21, 22] 
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The calculated solubility parameter of KTZ, HPMC and SOL were 20.60, 
24.61 and 19.41 MPa
1/2
, respectively.
 
The difference between the calculated solubility 
parameters of the polymers and the drug indicates that KTZ is likely to form solid 
dispersions with both polymers HPMC and SOL. By using the Van 
Krevelen/Hoftyzer equation the ∆δ values for KTZ/HPMC and KTZ/SOL were 4.01 
and 1.19 MPa
1/2
, respectively.  
 
Continuous manufacturing of strips via HME 
As shown in Figure 1 extrusion processing followed by downstream equipment was 
optimised to obtain the extrudates in the form of whitish strips. For the purposes of 
the study a specially designed die was coupled with the extruder to produce strips 
with approximately 0.5 mm thickness. The extruded strips were directed onto a 
compressed air facilitated conveyor belt and accurately cut into small pieces to 
produce strips of 1cm x 5cm size. During the process optimisation of KTZ loaded 
strips, a range of temperatures profiles varying from 120
°
C-140
°
C feed rates and 
screw speeds were evaluated as they play a key role in the product development. The 
process was eventually optimized to provide a throughput of 1Kg/h. SOL was chosen 
due its ability to enhance the dissolution rates of poorly water-soluble drugs in HME 
processing while HPMC possess very good adhesive properties. 
[14]
 In terms of the 
extrusion processibility, HPMC films appeared to be easier to handle compared to 
those of SOL due to the brittle nature of the latter. Therefore, the best two 
formulations (F1 and F2) with HPMC were taken for further characterisations The 
presence of MAS in the strip formulations facilitated smooth extrusion and 
subsequently cutting of the strips.  
 
Swelling capacity 
The hydration (swelling) profiles of the extruded films are presented in Table 2. The 
various formulations showed differences in their swelling profiles with the blank (no 
drug) HPMC and SOL strips showing slow initial hydration and gradual swelling over 
the measurement period. SOL containing strips generally showed significantly higher 
swelling (p < 0.05) capacity than HPMC.  
However, the KTZ containing strips showed very rapid hydration and swelling 
in the first 20 min, significantly higher than blank strips followed by a drastic 
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reduction after 40 min and eventually complete film disintegration occurred, 
suggesting it perhaps behaves as a semi-fast disintegrating system. This is due largely 
to the presence of MAS, which has high water affinity and hence cause rapid 
disintegration of the formulation. This is evidenced by the significantly very low 
swelling capacities recorded for the control strips in the absence of MAS. Further 
evaluation of the data shows that for blank formulations, peak swelling occurred at 60 
min, whilst the drug loaded strips (F1 and F2) showed peak swelling capacity in only 
20 min after which the values decreased significantly until they eventually 
disintegrated within a 60 min time period. This indicates that in addition to MAS, the 
amorphous nature of the drug present within the extruded strips contributed towards 
their initial hydration characteristics and eventual disintegration. The differences 
observed are interesting and expected to affect the dissolution profiles significantly 
since initial hydration and swelling, determine the rate of drug release by diffusion 
and/or eventual disintegration (erosion) of the polymer matrix. 
 
In vitro mucoadhesion studies 
Figure 2 shows the mucoadhesion (PAF, TWA and cohesiveness) profiles of the 
tested formulations. The HPMC based formulations showed higher PAF values than 
the SOL containing strips. In contrast, the drug loaded strips (F1 and F2) showed 
significantly (p<0.05) higher mucoadhesion (PAF and TWA) values compared to the 
blank strips, though the cohesiveness, which is the distance of travel before 
detachment, did not follow this trend, but it was still evident that the values were 
generally slightly higher for drug loaded strips than the blank ones. In addition, there 
was significant (p < 0.05) difference in PAF and the cohesiveness between the higher 
KTZ (F1) and lower KTZ (F2) loaded strips whilst the TWA of the two formulations 
(F1 and F2) was almost identical. An interesting observation from the results is that 
F2 showed higher PAF and lower cohesiveness than F1 (opposite effect) even though 
both had similar TWA values. This is because the TWA is a function of both PAF and 
the distance travelled (area under the force-distance plot) and therefore their (PAF and 
cohesiveness) combined effect (TWA) was similar for both F1 and F2. 
The above observations could be explained by the swelling capacity (Table 2), 
which plays an important role during the initial stages of mucoadhesion. In a typical 
mucoadhesion process the polymer hydrates initially which increases chain mobility. 
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This subsequently allows the chains to interpenetrate into mucin present on the model 
mucosal surface and eventually form strong interactions via either hydrogen or 
covalent bonding. Therefore, the drug-loaded strips, which showed rapid hydration 
and subsequent disintegration (Table 2), will have exhibited a stronger initial 
interaction with the model mucosal surface. Further, because the volume of moisture 
available was not high on the gelatine surface (compared to oral mucosa washed with 
saliva), it had a longer time to bond more strongly with the model mucosal surface. 
However, due to its high apparent water affinity at lower drug loading (F2), the initial 
strong bonds are disrupted as the strips disintegrated to form slippery mucilage and 
therefore the cohesiveness will be expected to decrease.  
Further, the control formulation (absence of MAS) showed higher PAF and 
TWA values than all the other formulations but lower cohesiveness than F1 and F2. 
Again, this could relate to the swelling and hydration behaviour as noted above, 
where the control strips showed very minimal hydration. This minimal hydration is 
enough to enable interaction with mucin but because the control strips did not hydrate 
to the same extent as F1 and F2, it will not have had the chance to travel over a longer 
distance before final detachment from the model mucosal substrate. Overall, it 
appears, that the main factors affecting the mucoadhesive properties were the drug 
content and the presence or absence of MAS in the formulations. Both the drug and 
MAS are not mucoadhesive and generally appear as brittle substances in 
formulations. The results also suggest that drug loaded strips will hydrate rapidly 
enough to allow drug diffusion out of the swollen gel but remain on the oral mucosa 
long enough to allow some level of absorption across the permeable oral (buccal and 
sublingual) mucosa.  
 
SEM/EDS analysis 
The surface morphology was examined by SEM using both secondary and 
backscattered electron imaging for both the drug and extruded strips (HPMC based). 
The strips containing HPMC polymer and excipients exhibited no drug crystals on the 
extrudate surface with KTZ (Figure 3). All extruded strips showed smooth surface. 
SEM/EDS was used to determine the elemental composition and distribution 
[23]
 of 
KTZ strips. As can be seen in Figure 4a, C, O, Na, Mg, Al, Si and Cl atoms were 
detected on the surface of extruded films, which are directly related to the materials 
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used during the HME processing. For example, the elemental distribution of Mg, Si 
and Al indicates the presence of the synthetic amorphous MAS (Mg.AlSiO3.2H2O) in 
the extruded strips. As expected, the most abundant element was carbon (which is 
present in a majority of the drugs and additives used in oral drug delivery) in both 
KTZ and all polymer/excipients used in this study.  
Since none of the excipients/compounds, used during the extrusion process, contains 
Cl atoms in their chemical structures, it was treated as a marker atom. Therefore, any 
presence of Cl atoms in the extruded strips would have come from the drug itself. As 
can be seen in Fig. 4b that KTZ pure exhibits a homogenous distribution of Cl atoms 
in EDS mapping indicated by green color. Similarly, the distribution of KTZ on the 
surface of the strips was visualized by EDS elemental mapping of Cl atoms (Fig. 4b). 
Similar to the KTZ pure the distribution of Cl atoms on the surface of the 
continuously extruded strips was homogenous. Backscatter electron images (BEI) 
show the sample morphology, while the background subtracted net-count Cl Kα X-
ray maps and overlays of the X-ray maps onto the BEI show the homogenous 
distribution of Cl in the sample. From the EDS mapping analysis it is obvious that 
KTZ is homogenously dispersed into the manufactured strips during the extrusion 
processing.  
 
Thermal analysis 
Differential scanning calorimetry (DSC) was used to analyse the solid state of the 
pure API, polymers, their physical mixtures (PM) and active extruded strips (EXT). 
The overall findings from DSC results are summarized in Figures. 5a and b. The 
thermograms of pure KTZ showed an endothermic transition corresponding to its 
melting at 150.32
°
C (∆H = 98.78 J/g) with an onset at 147.88
°
C. Similarly, the pure 
polymer showed a thermal transition via a clear step change at 158.76
°
C 
corresponding to the Tg of HPMC and 59.23
°
C corresponding to Tg of NaCMC, 
respectively (Figure 5a). In addition, SRB and PEG exhibited sharp thermal 
transitions due the melting at 95.92 and 50.37
°
C, respectively (Figure 5a) while 
amorphous MAS showed a flat line. The physical mixtures exhibited endothermic 
peaks (Figure 5a) corresponding to the initial substances at slightly shifted 
temperatures indicating the drug existence in its crystalline form. In the physical 
mixtures of F1 and F2, three endothermic peaks were visible (Figure 5b), one at 
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51.30
°
C corresponding to the melting peak of crystalline PEG present in the mixture 
followed by the transition at 98.52
°
C due to the melting of SRB. The endothermic 
peak at 150.25
°
C corresponds to the melting of the crystalline KTZ. Furthermore, the 
extruded formulations presented only one endothermic peak between 47.36 and 
47.97
°
C that was attributed to SRB. The absence of melting endothermic KTZ peaks 
suggests the presence of the drug in amorphous state. 
[21, 24, 25]
  
 
 
Transmission X-ray diffraction analysis 
The extruded strips, including pure drug and physical mixtures of the same 
composition as well as pure compounds were studied by transmission X-ray 
diffraction analysis in order to examine the crystalline state of the drug.  As depicted 
in Figure 6a the diffractograms of pure KTZ presented distinct peaks at 6.75, 17.50, 
19.08, 20.42, 23.79, 24.42, 28.22 2θ, while PEG showed two distinct peaks with 
relatively high intensity at 19.25 and 22.31 2θ. Similarly pure SRB showed its 
characteristic crystalline peaks at positions ranging from 11 to 35.20 2θ. Due to their 
amorphous nature, HPMC and MAS showed typical amorphous halos in the 
diffractograms.  
The physical mixture of both formulations presented identical peaks (data not 
shown) at lower intensities suggesting that the drug retain its crystalline properties. In 
the extruded strip formulations (Figure 6b) there were two distinct peaks that 
correspond to the presence of PEG, however no peaks due to the crystalline drug were 
observed.  The absence of KTZ peaks strongly suggests the presence of amorphous 
API in the extruded solid dispersion containing oral strips. 
 
In vitro dissolution study 
The main challenge for this study was to increase the dissolution rate of the poorly 
water soluble KTZ (water solubility 17 µg/ml) [15] in order to provide a rapid release. 
In Fig. 7, it can be seen that extruded strips containing 20% of KTZ (F1) provided 
rapid dissolution rates (cumulative release of 70% in 60 min at pH 6.8) compared to 
bulk KTZ that presented significantly slower dissolution. The result was 
complemented by previous studies reported elsewhere and is expected given the pKa 
values for KTZ (2.94, 6.15). 
[26]
 This enhancement of the dissolution can be attributed 
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to the formation of amorphous solid dispersions of KTZ in the extruded strips. In 
addition to the hydrophilic polymers, the presence of the inorganic MAS contributed 
to the enhanced release of KTZ. It has been reported that MAS releases silicic acid, 
Mg
2+
 and Al
3+
 
[27, 28]
 ions in dissolution medium, which facilitate the dissolution rates 
of poorly water-soluble drugs. The extruded strips presented similar release patterns 
and the 20% KTZ loaded formulations provided slightly faster release rates compared 
to those of 15% (w/w). Application of a single factor non-parametric statistical test of 
significance - Kruskal–Wallis test (p > 0.05) to the results showed no significant 
differences between the release profiles. Nevertheless, the HME extruded strips 
showed excellent release patterns that could provide fast onset action in future clinical 
trials.   
Conclusions 
HME was successfully employed to manufacture oral KTZ loaded strips in a 
continuous mode. EDS analysis revealed a homogeneous drug distribution on the 
surface of the extruded strips while thermal analysis and X-ray diffraction studies 
showed the presence of amorphous drug in the strips due to the intense mixing during 
the extrusion processing. The presence of KTZ in amorphous state facilitated 
enhanced in vitro dissolution rates at five orders of magnitude compared to the bulk 
drug substance. The use of MAS also favoured smooth processing of the extruded 
strips followed by rapid hydration, swelling and eventually enhanced dissolution rates 
of the poorly water-soluble ketoconazole. 
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TABLES 
Table 1: Formulation composition of the KTZ oral strips (w/w %) 
Excipients F1 F2 F3 F4 HPMC 
(Blank) 
SOL 
(Blank) 
Control 
KTZ 20 15 20 15 - - - 
HPMC 30 40 - - 50 - 60 
SOL - - 30 40 - 50 - 
MAS 10 10 10 10 10 10 - 
PEG 20 15 20 15 20 20 20 
SRB 10 10 10 10 10 10 10 
NaCMC 10 10 10 10 10 10 10 
 
Table 2: Swelling profiles for the different formulations tested showing differences in 
hydration behaviour based on type of polymer and drug content 
 
Formulation Swelling (%) 
Time (min) 
20 40 60  80  
HPMC (Blank) 203.53±0.30 232.69±0.25 239.74±0.30 226.60±0.1 
SOL (Blank) 292.73±0.25 413.94±0.33 427.27±0.30 418.79±0.2 
Control 4.41±0.31 5.25±0.30 5.09±0.20 3.65±0.20 
F1 509.58±0.35 395.02±0.30 Disintegrated 
F2 408.70±0.30 263.35±0.20 Disintegrated 
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Figures caption list 
Figure  1  i) Continuous manufacturing process of oral KTZ strips via 
advanced HME process, ii) digital photographs of representative 
extruded KTZ strips. 
Figure 2 In vitro mucoadhesion data for the various blank and drug loaded 
formulations showing changes in mucoadhesive properties with 
change of polymer and drug loading content.  
Figure 3 SEM images of KTZ loaded oral strips (F1). 
Figure 4 a) Elemental analysis mapping of the extruded strips using EDS (F2) 
and b) EDS mapping of the Cl atoms (marker atom) of both KTZ 
and extruded strips to analyse the drug distribution on the surface of 
the continuously extruded strips. 
Figure 5 DSC thermograms of a) bulk KTZ, MAS, PEG, SRB, HPMC, 
NaCMC and b) extruded strips (EXT) and physical mixtures. 
Figure 6 XRD-transmission diffractograms of a) pure substances (MAS, 
SRB, HPMC, KTZ and PEG) and b) extruded strips (F1 and F2) and 
bulk KTZ.  
Figure 7 In vitro dissolution analysis of KTZ and extruded strips in phosphate 
buffer pH 6.8 (n = 3, 37±0.5°C; 100 rpm). 
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